-
1 Comment
Shenzhen Chipscreen Biosciences Co., Ltd is currently in a long term uptrend where the price is trading 4.9% above its 200 day moving average.
From a valuation standpoint, the stock is 499.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 57.7.
Shenzhen Chipscreen Biosciences Co., Ltd's total revenue rose by 84.5% to $83M since the same quarter in the previous year.
Its net income has dropped by 424.1% to $-7M since the same quarter in the previous year.
Finally, its free cash flow fell by 146.4% to $-97M since the same quarter in the previous year.
Based on the above factors, Shenzhen Chipscreen Biosciences Co., Ltd gets an overall score of 2/5.
| ISIN | CNE100003LW0 |
|---|---|
| Exchange | SHG |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.57 |
|---|---|
| Market Cap | 7B |
| Target Price | 32.68 |
| PE Ratio | None |
| Dividend Yield | None |
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines for the treatment of human diseases in five therapeutic areas, including cancer, metabolic diseases, autoimmune disorders, central nervous system disorders, and antivirals. It is developing chidamide, a subtype-selective benzamide inhibitor of histone deacetylase (HDAC) primarily targeting subtypes 1, 2, 3 of class I HDAC; chiglitazar, a new-generation insulin sensitizing candidate drug for the treatment of type 2 diabetes mellitus; and chiauranib, an aurora B/VEGFR/PDGFR /c-Kit/CSF1R inhibitor. The company also develops CS23546, a small molecule PD-L1 inhibitor for CS23546 is a small molecule PD-L1 inhibitor; CS32582, a highly selective small molecule allosteric inhibitor of tyrosine kinase 2; CS12192, a highly selective JAK3 kinase inhibitor; and other drugs, such as CS12088 and CS23074. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is headquartered in Shenzhen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 688321.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
